The effect of olive oil in the treatment of non-alcoholic fatty liver disease

Not Applicable

• Conditions: onalcoholic fatty liver.; Nonalcoholic fatty liver disease (NAFLD)

• Registration Number: IRCT2016011825957N2
• Lead Sponsor: Oil Version Factory

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

having NAFLD by medical diagnosis (using ultrasound); BMI = 25 and above; willingness to participate in the study, the absence of diabetes mellitus type 2;heart disease; cardiovascular and liver disease (cirrhosis, liver disease Alcohol, viral hepatitis, autoimmune hepatitis, primary biliary cirrhosis, biliary obstruction, liver damage induced by drugs hereditary Hemochromatosis, sclerosis cholangitis and antitrypsin deficiency of a-a-1);other serious diseases such as cancer; kidney failure and celiac disease, etc); lack of pregnancy ;lactation; lack of drugs that are causing fatty liver (methotrexate, tamoxifen, Valproate, etc.); avoiding the use of any type of lipid lowering agents (atorvastatin, lovastatin, pravastatin, etc.); fibrates (gemfibrozil, fenofibrate); lack of malnutrition; have no special diets such as vegan and vegetarian; not drinking alcohol and having over 18 years of age. Exclusion criteria: non-compliance with recommended diet for more than 15 days over 3 months; acute or infectious disease; hospitalization or in cases where the criteria mentioned is.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Insulin resistance index. Timepoint: The beginning and end of the study. Method of measurement: blood test.;TNF-Alpha. Timepoint: Before the intervention, after intervention. Method of measurement: blood test.;Oxidative stress index. Timepoint: Before the intervention, after intervention. Method of measurement: blood test.

Secondary Outcome Measures

Name	Time	Method
BMI. Timepoint: Beginning of the study and end of each month. Method of measurement: Balance-Meter.;Changes in body composition (fat and muscle mass). Timepoint: Before the intervention, after the intervention. Method of measurement: BIA devices.;The degree of fatty liver. Timepoint: Before the intervention, after the intervention. Method of measurement: Ultrasound.;Waist Circomfrance. Timepoint: Beginning of the study and end of each month. Method of measurement: Meter.;Blood pressure. Timepoint: Beginning of the study and end of each month. Method of measurement: Barometr.